Overview
Blastocystis is one of the most widespread and prevalent single-celled organisms in the human intestine,[1] and often the most commonly found organism in parasite surveys of stool.[2] For much of the past century it was treated as a parasite. Today its status is genuinely unsettled, and the evidence has shifted substantially.
Recent research finds Blastocystis more often in healthy people than in people with gut disorders, and associates it with more diverse gut bacteria and more favorable metabolic health.[3][4][5] At the same time, researchers still lack reliable tools to tell harmless colonization from infection, and it may cause disease under certain circumstances.[3]
That makes Blastocystis one of the clearest examples of why a "parasite" flag on a stool test needs interpretation, not automatic treatment.
Classification
- Group: Stramenopiles
- Phylum: Bigyra
- Family: Blastocystidae
- Genus: Blastocystis
Blastocystis is a stramenopile,[6] a member of a diverse lineage that also includes diatoms, brown algae, and water molds. Although medicine groups it with the intestinal protozoa, it is only distantly related to amoebae such as Entamoeba. The name Blastocystis hominis is still common on lab reports, but it is increasingly replaced by Blastocystis sp. with a subtype designation. That is because many genetic types exist, and humans host numerous subtypes that are also found in animals.[2]
This genetic diversity may be key to understanding Blastocystis. Differences between subtypes have been proposed as a possible explanation for conflicting findings about whether it causes symptoms.[2][1]
From Parasite to Microbiome Member
The case for a pathogen
A 2008 review concluded that accumulating epidemiological, animal, and laboratory data strongly suggested Blastocystis is a pathogen, and proposed that pathogenic and nonpathogenic genotypes could explain conflicting clinical observations.[2] Earlier research was also hampered by the organism's varied forms and by a lack of standardized lab techniques, which led to confusion and, in some cases, misinterpretation of data.[2]
The case for a common commensal
DNA-based detection has since shown that Blastocystis is much more common than previously thought, at least in some regions and populations.[1] Studies of the gut microbiome have changed the picture further:
| Study | Key finding |
|---|---|
| Andersen & Stensvold, 2016 (review) | Once established, a stable part of the gut microbiota; more common in healthy people than in patients with infectious, functional, or inflammatory bowel disease[3] |
| Audebert et al., 2016 (48 colonized vs 48 non-colonized) | Colonized people had higher bacterial diversity, more Clostridia, and fewer Enterobacteriaceae[4] |
| Tito et al., 2019 (616 healthy individuals, 107 IBD patients) | Present in 30% of the healthy population cohort vs 4% of IBD patients[6] |
| Piperni et al., 2024 (56,989 metagenomes, 32 countries) | Linked to more favorable cardiometabolic profiles and negatively associated with obesity[5] |
The authors of the diversity study concluded that Blastocystis colonization is usually associated with a healthy gut microbiota, rather than with the dysbiosis seen in inflammatory and metabolic diseases.[4]
Diet, Metabolism, and Blastocystis
A global-scale study of 56,989 metagenomes from 32 countries found that Blastocystis prevalence follows patterns linked to geography, lifestyle, and diet. Its presence was associated with a distinct bacterial signature and with more favorable cardiometabolic profiles. In a diet intervention involving 1,124 people, improvements in diet quality were linked to weight loss and to increases in Blastocystis prevalence and abundance.[5]
The researchers suggested a potentially beneficial role for Blastocystis.[5] These are associations, however. It remains possible that Blastocystis is a marker of a healthy gut and diet rather than a cause of better health. For practical steps toward a more diverse gut microbiome, see our guide on how to improve your gut microbiome and our gut-healthy diet guide.
Subtypes and the Rest of the Microbiome
In the Flemish Gut Flora Project, Blastocystis subtypes were strongly associated with overall gut community composition, more strongly than host factors were. All subtypes were less common in people with a Bacteroides-dominated gut profile, and subtypes 3 and 4 were inversely correlated with Akkermansia, suggesting different subtypes may relate differently to host health.[6] The authors noted that these findings are relevant to selecting donors for fecal microbiota transplantation.[6]
What a Positive Stool Test Means
If Blastocystis appears on a stool test:
- It is common and often found in healthy people.[3] A positive result alone is not a diagnosis.
- Look for other causes of symptoms. Persistent diarrhea, pain, or bloating can have many causes, including other infections, IBS, SIBO, or inflammatory bowel disease.
- Treatment is a clinical decision. There are no validated tools yet to distinguish colonization from infection,[3] so clinicians weigh symptoms, other test results, and the full clinical picture.
See our microbiome testing guide for help interpreting stool test results. Other intestinal protozoa with clearer disease roles include Giardia lamblia, Cryptosporidium, and Entamoeba histolytica.
When to See a Clinician
See a clinician for diarrhea lasting more than a couple of weeks, blood in the stool, unintended weight loss, fever, or abdominal pain that wakes you at night. These symptoms warrant evaluation regardless of whether Blastocystis was found.
This page is for educational purposes and is not medical advice. Consult a qualified healthcare provider about stool test results and digestive symptoms.